Analyzing the Changes in Eye Axis Length and Corneal Curvature in Central China
NCT ID: NCT06126302
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
60000 participants
OBSERVATIONAL
2023-11-05
2023-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
China Axial Length Study
NCT05770661
Development and Pathological Changes of High Myopia Among Children and Adolescents in China
NCT03533647
Axis Length and Its Relationship With Refractive Error in Chinese University Students
NCT04666870
Developmental Profile of Ocular Refraction in Patients With Congenital Cataract
NCT02761850
The Relationship of Relative Corneal Refractive Power Shift and Axial Length in Adolescents With Orthokeratology Lens
NCT05348369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before 1930
the patients were divided into ten groups according to the decade of their birth: before 1930
Birth year
we divided the patients according to patients' birth year
1930-1939
the patients were divided into ten groups according to the decade of their birth: 1930-1939
Birth year
we divided the patients according to patients' birth year
1940-1949
the patients were divided into ten groups according to the decade of their birth: 1940-1949
Birth year
we divided the patients according to patients' birth year
1950-1959
the patients were divided into ten groups according to the decade of their birth: 1950-1959
Birth year
we divided the patients according to patients' birth year
1960-1969
the patients were divided into ten groups according to the decade of their birth: 1960-1969
Birth year
we divided the patients according to patients' birth year
1970-1979
the patients were divided into ten groups according to the decade of their birth: 1970-1979
Birth year
we divided the patients according to patients' birth year
1980-1989
the patients were divided into ten groups according to the decade of their birth: 1980-1989
Birth year
we divided the patients according to patients' birth year
1990-1999
the patients were divided into ten groups according to the decade of their birth: 1990-1999
Birth year
we divided the patients according to patients' birth year
2000-2009
the patients were divided into ten groups according to the decade of their birth: 2000-2009
Birth year
we divided the patients according to patients' birth year
after 2009
the patients were divided into ten groups according to the decade of their birth: after 2009
Birth year
we divided the patients according to patients' birth year
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Birth year
we divided the patients according to patients' birth year
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
7 Years
130 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Min Ke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Min Ke
Department of ophthalmology, Zhongnan Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20231105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.